Jul. 24 at 2:00 PM
$QNCX Pfizer’s investment in Quince Therapeutics comes through Pfizer Ventures—their corporate venture capital arm:
• According to Tracxn, Quince has raised a total of
$108 million, with Pfizer Ventures listed among its investors alongside Takeda Ventures and Breakout Labs .
• Additionally, Dr. Margaret McLoughlin, formerly a Partner in Pfizer Ventures and Executive Director in Pfizer’s Worldwide Business Development, served on Quince’s board through April 2019. That indicates Pfizer’s involvement dates back at least to the late 2010s .
📅 Summary:
• Pfizer Ventures is a notable investor in Quince’s multi-round fundraising, helping to drive its growth.
• Dr. McLoughlin’s role (until April 2019) points to Pfizer’s involvement in Quince’s strategy and direction since around that time.
